Genscript Biotech Corporation
HKEX:1548.HK
12.1 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 1,446.403 | 1,023.999 | 1,180.971 | 629.058 | 252.397 | 494.558 | 123.857 | 136.464 | 103.72 | 25.637 | 22.457 |
| Short Term Investments
| 481.647 | 228.894 | 222.533 | 137.458 | 148.693 | 70.056 | 3.088 | 0 | 0 | 2.526 | 4.105 |
| Cash and Short Term Investments
| 1,928.05 | 1,463.712 | 1,405.712 | 772.382 | 426.524 | 564.614 | 126.945 | 136.464 | 103.72 | 28.163 | 26.562 |
| Net Receivables
| 217.443 | 104.277 | 142.439 | 141.748 | 73.067 | 67.843 | 255.351 | 20.022 | 16.914 | 12.157 | 9.01 |
| Inventory
| 53.346 | 59.935 | 44.358 | 31.745 | 16.486 | 12.429 | 6.878 | 4.237 | 2.025 | 1.777 | 1.404 |
| Other Current Assets
| 259.917 | 347.845 | 48.759 | 53.165 | 63.403 | 104.633 | 8.721 | 3.186 | 10.355 | 1.695 | 1.585 |
| Total Current Assets
| 2,353.111 | 1,764.95 | 1,639.06 | 993.174 | 554.046 | 679.463 | 397.895 | 163.909 | 133.014 | 43.792 | 38.561 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 750.945 | 624.672 | 486.911 | 379.232 | 265.628 | 158.013 | 80.508 | 43.735 | 37.719 | 37.53 | 38.271 |
| Goodwill
| 1.356 | 2.547 | 14.151 | 14.116 | 15.245 | 15.287 | 1.47 | 1.384 | 0 | 0 | 0 |
| Intangible Assets
| 18.648 | 23.811 | 26.423 | 26.02 | 25.482 | 19.642 | 2.467 | 2.13 | 0.901 | 0.349 | 0.264 |
| Goodwill and Intangible Assets
| 20.004 | 26.358 | 40.574 | 40.136 | 40.727 | 34.929 | 3.937 | 3.514 | 0.901 | 0.349 | 0.264 |
| Long Term Investments
| 85.407 | 16.029 | 18.467 | 13.988 | 7.282 | 11.278 | 1.75 | 42.338 | 35.883 | 35.575 | 0 |
| Tax Assets
| 16.506 | 15.045 | 5.09 | 3.702 | 5.701 | 11.842 | 7.525 | 4.911 | 2.737 | 2.304 | 0 |
| Other Non-Current Assets
| 161.329 | -15.045 | -5.09 | -3.702 | -5.701 | -11.842 | -7.525 | -47.249 | -38.62 | -37.879 | 6.739 |
| Total Non-Current Assets
| 1,034.191 | 667.059 | 545.952 | 433.356 | 313.637 | 204.22 | 86.195 | 47.249 | 38.62 | 37.879 | 45.274 |
| Total Assets
| 3,387.302 | 2,546.383 | 2,233.868 | 1,447.406 | 889.411 | 916.976 | 504.264 | 226.032 | 182.074 | 92.38 | 83.835 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 39.959 | 55.755 | 30.176 | 23.376 | 17.627 | 11.187 | 8.154 | 4.352 | 2.414 | 2.87 | 1.848 |
| Short Term Debt
| 65.878 | 44.785 | 8.031 | 47.23 | 18.777 | 10.502 | 0 | 0 | 0 | 8.172 | 7.39 |
| Tax Payables
| 25.569 | 16.153 | 25.334 | 12.327 | 4.044 | 17.302 | 14.01 | 5.665 | 4.598 | 0.85 | 0 |
| Deferred Revenue
| -8.867 | -44.785 | -8.031 | -47.23 | -18.777 | -10.502 | 0 | 0 | 0 | -8.172 | 0 |
| Other Current Liabilities
| 397.841 | 490.223 | 383.129 | 304.535 | 206.878 | 142.328 | 264.562 | 34.863 | 28.48 | 26.318 | 20.647 |
| Total Current Liabilities
| 494.811 | 545.978 | 413.305 | 327.911 | 224.505 | 153.515 | 272.716 | 39.215 | 30.894 | 29.188 | 29.885 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 351.112 | 567.227 | 381.86 | 1.26 | 1.748 | -4.018 | -2.887 | -2.349 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 64.678 | 18.177 | 15.535 | 13.476 | 281.67 | 266.145 | 2.887 | 2.349 | 1.932 | 1.445 | 0 |
| Deferred Tax Liabilities Non-Current
| 5.622 | 8.012 | 7.73 | 11.271 | 5.582 | 4.017 | 0.342 | 0.447 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 426.725 | -26.189 | -23.265 | -24.747 | -287.252 | 4.018 | 2.887 | 2.349 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 848.137 | 567.227 | 381.86 | 1.26 | 1.748 | 270.162 | 3.229 | 2.796 | 1.932 | 1.445 | 0 |
| Total Liabilities
| 1,342.948 | 1,183.715 | 846.175 | 631.815 | 517.113 | 423.677 | 275.945 | 42.011 | 32.826 | 30.633 | 29.885 |
| Equity: | |||||||||||
| Preferred Stock
| 611.515 | 0 | 0 | 0 | 10.021 | 14.185 | 9.459 | 23.406 | 14.113 | 0 | 0 |
| Common Stock
| 2.121 | 2.111 | 2.096 | 1.954 | 1.879 | 1.836 | 1.734 | 1.692 | 1.6 | 0.05 | 0.364 |
| Retained Earnings
| -611.515 | -502.248 | -275.397 | -175.006 | 29.939 | 126.913 | 104.764 | 81.276 | 55.106 | 37.602 | 31.427 |
| Accumulated Other Comprehensive Income/Loss
| 1,398.403 | 49.573 | 60.775 | 24.922 | -10.021 | -14.185 | -9.459 | -23.406 | -14.113 | 24.062 | 20.739 |
| Other Total Stockholders Equity
| -9.445 | 1,461.105 | 1,258.518 | 1,049.835 | 350.986 | 349.915 | 111.311 | 94.645 | 92.542 | 0 | 0 |
| Total Shareholders Equity
| 1,391.079 | 1,010.541 | 1,045.992 | 901.705 | 382.804 | 478.664 | 217.809 | 177.613 | 149.248 | 61.714 | 52.53 |
| Total Equity
| 2,044.354 | 1,362.668 | 1,387.693 | 815.591 | 372.298 | 493.299 | 228.319 | 184.021 | 149.248 | 61.747 | 52.563 |
| Total Liabilities & Shareholders Equity
| 3,387.302 | 2,546.383 | 2,233.868 | 1,448.492 | 889.411 | 916.976 | 504.264 | 226.032 | 182.074 | 92.38 | 83.835 |